Fig. 4From: Identification of potential immunomodulators from Pulsatilla decoction that act on therapeutic targets for ulcerative colitis based on pharmacological activity, absorbed ingredients, and in-silico molecular dockingRepresentative UPLC–QQQ-MS chromatograms of the identified components from R. pulsatilla A, C. fraxini B, C. phellodendri, and R. coptidis C in mouse plasma and colon samples after oral administration of 531.5 mg/kg BTWT (n = 5 mice per treatment group)Back to article page